Renaissance Technologies
SKBI

Renaissance Technologies’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Renaissance Technologies’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-52,300
Closed -$50K – 3571
2015
Q3 		$50K Buy
52,300
+9,942
+23% +$15.9K ﹤0.01% 3081
2015
Q2 		$113K Buy
42,358
+26,558
+168% +$90.9K ﹤0.01% 3076
2015
Q1 		$62K Buy
15,800
+3,741
+31% +$15.9K ﹤0.01% 3063
2014
Q4 		$51K Sell
12,059
-2,541
-17% -$11K ﹤0.01% 2874
2014
Q3 		$61K Buy
+14,600
New +$79.3K ﹤0.01% 2704

Other funds holding SKBI

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Renaissance Technologies's SKBI Position: Q4 2015 in Review

Renaissance Technologies sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2015, closing a stake of 52,300 shares — an estimated $50K sold.

Renaissance Technologies first reported a position in SKBI in Q3 2014 and held it in 5 quarters. The position peaked at $113K in Q2 2015. 1 fund tracked by Wall St. Rank holds SKBI as of Q4 2015.

  • Renaissance Technologies reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2015 after selling out during the quarter.
  • Renaissance Technologies sold 52,300 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2015, an estimated $50K.
  • Renaissance Technologies first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q3 2014 and held it in 5 quarters.
  • Renaissance Technologies's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $113K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2015.

Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.